<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2015-04-20 05:17:21Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Antiretroviral drug Abacavir Reverse-transcriptase inhibitor Nevirapine Efavirenz Patent Raltegravir Chemistry Organic chemistry Organofluorides |
Add to Reading List |
ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL | DEPARTMENT OF BIOCHEMISTRY FRONTIERS PROFESSOR KENNETH JOHNSON Roger J. Williams Centennial Professor of Biochemistry, University of Texas, USA DATEDocID: 1pw8Q - View Document |
 | Human Immunodeficiency Virus (HIV) is a potential precursor to Acquired Immune Deficiency Syndrome (AIDS), which commonly treated with a mixture of reverse transcriptase inhibitors (RTI) and protease inhibitors (PI). AdaDocID: 1pbRe - View Document |
 | New Zealand Consumer Medicine Information Viramune Tablets and Oral Suspension NevirapineDocID: 1gvCL - View Document |
 | Viramune Tablets Viramune Oral Suspension Nevirapine Consumer Medicine InformationDocID: 1gtrY - View Document |
| ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOLDocID: 1fNy0 - View Document |